Shots:
- The US FDA has granted full approval to KBroVet (potassium bromide chewable tablets) under NADA for the control of seizures associated with idiopathic epilepsy in dogs
- KBroVet offers benefits for dogs, incl. renal excretion via glomerular filtration for those with liver issues, once-daily dosing, & flavored, chewable tablets formulated specifically for dogs
- KBroVet has a t½ of ≥21 days, reducing concentration fluctuations if a dose is missed after steady state, plus is available in 60 & 180-count bottles, & will transition to fully approved labeling around Apr-May 2026
Ref: Prnewswire | Image: PRNPharmacal | Press Release
Related News: PBI-Gordon Companies Acquires TriviumVet, Expanding its Animal Healthcare Product Portfolio
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
